[
    {
        "releaseTime": "Feb-06-23 11:01AM",
        "title": "AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-report-q4-earnings-160104987.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-06-23 06:35AM",
        "title": "Abbvie plans to lift $2 billion cap on deals - WSJ",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvie-plans-lift-2-billion-113540113.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-06-23 05:30AM",
        "title": "AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/5bcfc1d3-b258-3a37-bc76-b688b4e2b9c0/abbvie-aims-for-new-drugs-to.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-05-23 08:46AM",
        "title": "12 Safe Stocks to Buy For Long-Term",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-safe-stocks-buy-long-134607791.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-05-23 07:00AM",
        "title": "AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three years",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvies-nyse-abbv-investors-pleased-120035536.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-04-23 08:30AM",
        "title": "2 Stocks Down More Than 6% to Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2e0d39a8-fbe3-373f-a0a8-d37e994f6b1b/2-stocks-down-more-than-6%25-to.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-04-23 07:45AM",
        "title": "3 Unstoppable Dividend Stocks to Buy in February",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/711633f8-6168-3fe6-8893-d95841fe4830/3-unstoppable-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 05:31PM",
        "title": "AbbVie Q4 Preview: What's in Store?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-q4-preview-whats-store-223110835.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 02:15PM",
        "title": "How Revance Therapeutics, The IBD 50's No. 1 Stock, Is Taking On 'Prestige' Medical Aesthetics",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/06b43a0a-b7c8-33b3-a988-f8c7065e7b23/how-revance-therapeutics%2C-the.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 01:19PM",
        "title": "10 Hot Healthcare Stocks To Buy Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-hot-healthcare-stocks-buy-181956435.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 10:07AM",
        "title": "If You Want Tons of Passive Income in the Future , Buy These 2 Stocks",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6bf0dc3d-ee3d-3b96-9133-fafd627a2771/if-you-want-tons-of-passive.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 09:00AM",
        "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/investors-heavily-search-abbvie-inc-140002295.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 09:00AM",
        "title": "2 Steady Stocks to Buy in a Recession",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e3f627f9-3e5b-3d8d-8550-281554dbee0e/2-steady-stocks-to-buy-in-a.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 07:00AM",
        "title": "Top Fund Manager Found A Way To Make Money While Others Lose",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/c8b09758-c5a7-3c87-a4f9-b195a5e1b290/top-fund-manager-found-a-way.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 01:15AM",
        "title": "15 Cheapest Dividend Aristocrats Right Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-cheapest-dividend-aristocrats-now-061521556.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 12:58AM",
        "title": "Is AbbVie (ABBV) an Attractive Investment Option?",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-attractive-investment-option-055817493.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 12:52PM",
        "title": "Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/32ef9696-a4fb-3587-82e0-9eefba6d9a75/here%27s-what%27s-next-for.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 10:01AM",
        "title": "AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-earnings-expected-grow-150103650.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 09:53AM",
        "title": "2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/b6ed3095-ddca-3301-96c4-0fca342ca4b4/2-surefire-stocks-to-buy-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 09:00AM",
        "title": "3 Ultra-Profitable Businesses to Invest in for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/4fedfdcc-651e-39e7-aac0-de0a60b64e81/3-ultra-profitable-businesses.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 07:55AM",
        "title": "Merck (MRK) Beats Q4 Earnings and Revenue Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/merck-mrk-beats-q4-earnings-125512556.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 01:32PM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-183218523.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 12:36PM",
        "title": "Americas top-selling drug Humira loses monopoly status",
        "publisher": " Yahoo Finance Video",
        "webUrl": "https://finance.yahoo.com/video/america-top-selling-drug-loses-173623041.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 06:00AM",
        "title": "AbbVie Inc. (NYSE:ABBV) is a favorite amongst institutional investors who own 70%",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-favorite-110031131.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 05:55AM",
        "title": "3 Juicy Dividend Stocks in Warren Buffett's Secret Portfolio to Buy in February",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/07104819-f2d2-3d6b-90d4-d1697e4ac378/3-juicy-dividend-stocks-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 04:04PM",
        "title": "AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/0813e7fa-501a-3817-98a4-73e590a163c8/abbvie%27s-two-decade-humira.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 01:07PM",
        "title": "First Humira Biosimilar Price Highlights Cost-Saving Challenges",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/17bde80c-13ac-3415-afee-a6cbe02f083a/first-humira-biosimilar-price.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 10:25AM",
        "title": "UPDATE 1-Amgen launches biosimilar version of AbbVie's Humira",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-amgen-launches-biosimilar-version-152539306.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 09:25AM",
        "title": "15 Largest Ophthalmology Companies in the World",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-largest-ophthalmology-companies-world-142505121.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 08:15AM",
        "title": "Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-q4-earnings-revenues-131501821.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 07:36AM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-123635489.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:18AM",
        "title": "AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvies-humira-gets-u-rival-111842850.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:01AM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-110100507.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Blockbuster AbbVie drug Humira to face competition in US for first time",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/4161a541-ce1f-3452-a3b4-0987edf7fbe2/blockbuster-abbvie-drug.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S.",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/2266a199-b468-3306-9beb-c3998aa24cda/blockbuster-arthritis-drug.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Amgen launches biosimilar version of AbbVie's Humira",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/amgen-launches-biosimilar-version-abbvies-110000693.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-30-23 05:57PM",
        "title": "'Go big or go home': How a Peninsula biotech looks to win in Humira biosimilar 'feeding frenzy'",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/fc869b9e-6e47-3378-b4df-ba15c9205986/%27go-big-or-go-home%27%3A-how-a.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-30-23 05:45PM",
        "title": "AbbVie (ABBV) Stock Moves -0.43%: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-moves-0-224510335.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-30-23 10:11AM",
        "title": "Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/eli-lilly-lly-lymphoma-candidate-151103024.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-30-23 06:58AM",
        "title": "What Makes AbbVie (ABBV) Stock Attractive?",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/makes-abbvie-abbv-stock-attractive-115844733.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-28-23 05:30AM",
        "title": "2 of the Best Dividend Stocks to Own in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/1b758875-d8a2-35ef-a21a-65fa9b6ab045/2-of-the-best-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-26-23 10:20AM",
        "title": "12 Cheap Blue Chip Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-blue-chip-stocks-152041107.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 05:20PM",
        "title": "3 Gene Editing Stocks to Buy Now OR Youll Be Kicking Yourself Later",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-gene-editing-stocks-buy-222018942.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 10:37AM",
        "title": "12 Cheap Biotech Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-biotech-stocks-buy-153727204.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 09:00AM",
        "title": "Allergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/allergan-aesthetics-takes-360-approach-140000083.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 07:05AM",
        "title": "3 Reasons to Buy AbbVie and 2 Reasons Not to Buy",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2d66f5a9-df8d-30f8-8f7c-1e88b71f473e/3-reasons-to-buy-abbvie-and-2.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 06:00AM",
        "title": "Want Safety and Growth in 2023? Try These Dividend Stocks.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bd71ffda-96a5-3909-bbc3-c8929ff40ae6/want-safety-and-growth-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-23-23 05:45PM",
        "title": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-224510908.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-23-23 09:00AM",
        "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002846.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-22-23 07:05PM",
        "title": "2 Top Passive-Income Stocks to Own in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/633d2db6-6645-305b-9201-f0b8ed4dc254/2-top-passive-income-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-22-23 05:30AM",
        "title": "AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/20bcc229-7bc5-39c3-88db-cb21161f89c3/abbvie-is-set-to-lose-on-its.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-19-23 05:30AM",
        "title": "3 Unstoppable Stocks to Keep Buying in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/04cd187e-026b-30af-ac6d-168fadd32c0d/3-unstoppable-stocks-to-keep.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 05:32PM",
        "title": "One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/ad407f57-05f9-382d-a10e-93a424c58712/one-of-the-greatest-cancer.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 03:44PM",
        "title": "7 Biotech Stocks That Will Make You Rich in 10 Years",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-biotech-stocks-rich-10-204449431.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 09:53AM",
        "title": "2 Cheap Growth Stocks That Can Set You Up for Life",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c0831a57-6e87-3983-a821-a27b288843e5/2-cheap-growth-stocks-that.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 09:20AM",
        "title": "14 Best Dividend Stocks To Buy and Hold",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/14-best-dividend-stocks-buy-142029008.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 08:00AM",
        "title": "JUVÉDERM® VOLUX XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/juv-derm-volux-xc-improvement-130000644.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 05:45PM",
        "title": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-dips-more-broader-224510389.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 10:07AM",
        "title": "Could This FDA Approval Boost AbbVie's Stock?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/526955d0-9e60-3696-83aa-e7fb492d93fc/could-this-fda-approval-boost.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 10:00AM",
        "title": "12 Best DRIP Stocks To Own",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-best-drip-stocks-own-150032179.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 08:00AM",
        "title": "SkinMedica® Launches Even & Correct",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/skinmedica-launches-even-correct-130000589.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 07:45AM",
        "title": "With Competition on the Rise, Is AbbVie's Dividend Safe?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2c95e890-3e4a-328f-80ac-3a174bc284af/with-competition-on-the-rise%2C.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 06:03AM",
        "title": "AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/abbvie-eli-lilly-leave-uks-110320254.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 05:47AM",
        "title": "Is AbbVie a Good Dividend Stock to Buy on the Dip?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5f8a9da4-6c64-3c6f-be6b-7fc92bfb1df0/is-abbvie-a-good-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 09:00AM",
        "title": "Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/sirona-biochem-announces-termination-supply-140000910.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 08:45AM",
        "title": "5 Dividend Kings I Bought for My Portfolio",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6329730c-c4db-3ab9-af9a-b99e4a95ae35/5-dividend-kings-i-bought-for.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 06:34AM",
        "title": "US drugmakers withdraw from NHS pricing agreement as costs soar",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/71bf4065-58c4-3b36-a6eb-27f462b8bbb4/us-drugmakers-withdraw-from.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 04:24AM",
        "title": "UPDATE 1-AbbVie, Eli Lilly exit UK drug pricing agreement",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-abbvie-eli-lilly-exit-092402473.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-14-23 01:22PM",
        "title": "12 Cheap Monthly Dividend Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-monthly-dividend-stocks-182235031.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-14-23 10:03AM",
        "title": "A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/607887bb-0f3a-32d9-8879-78f883c49691/a-new-u.s.-law-aims-to-reduce.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-13-23 09:45AM",
        "title": "Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/eec3932c-130c-3c2d-a206-0d2c1bfa047b/want-to-get-richer%3F-3-best.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-12-23 05:00AM",
        "title": "Zacks Market Edge Highlights: EXAS, ZM, TSLA, ABBV, ZOM",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-market-edge-highlights-exas-100010824.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 04:01PM",
        "title": "The Stocks Behind 2022's Popular ETFs",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/stocks-behind-2022s-popular-etfs-210109806.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 07:50AM",
        "title": "3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/552035f1-06fe-324e-bd7a-04a4e5b84ea0/3-supercharged-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 07:10AM",
        "title": "If You Like Dividends, You Should Love These 3 Stocks",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bba50609-adca-397f-adb2-99c2fc7d6c65/if-you-like-dividends%2C-you.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 05:30AM",
        "title": "1 Hot Growth Stock to Buy Now, and 1 to Avoid",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/cb2d0740-bb0d-3b5c-a0e2-914e49ca6831/1-hot-growth-stock-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:45PM",
        "title": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-224510089.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 12:28PM",
        "title": "AbbVie (NYSE:ABBV) Is Paying Out A Larger Dividend Than Last Year",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-nyse-abbv-paying-larger-172842758.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:45AM",
        "title": "3 Passive Income Stocks That Are Screaming Buys in January",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0712124f-af1a-30ec-bca0-2d96da6c515a/3-passive-income-stocks-that.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:12AM",
        "title": "Abbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvie-raises-sales-outlook-two-141249692.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:02AM",
        "title": "UPDATE 2-Abbvie raises sales outlook of two immunology drugs to more than $17.5 bln in 2025",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-abbvie-raises-sales-outlook-140239478.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:00AM",
        "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002633.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 08:00AM",
        "title": "AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-anima-biotech-announce-collaboration-130000427.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 07:00AM",
        "title": "Fund Soars By Focusing On Income Stocks, Shunning Sector Bets",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/020c3dc4-45d5-310c-800b-a8c34fa51c1e/fund-soars-by-focusing-on.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:52AM",
        "title": "3 Top Dividend Kings to Buy for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/04b6528a-5a1c-3c0f-bffc-2054da0284c4/3-top-dividend-kings-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:31AM",
        "title": "Should Investors Worry About AbbVie's Dividend?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/28f3ee73-2be7-31af-9542-25055d6f7b39/should-investors-worry-about.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-09-23 12:48PM",
        "title": "These 15 Dividend Aristocrat stocks have been the best income builders",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/1b7e0d78-de46-3028-974a-09de73d8bbdb/these-15-dividend-aristocrat.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-09-23 07:01AM",
        "title": "QULIPTA Now Approved by Health Canada for the Preventive Treatment of Episodic Migraine in Adults",
        "publisher": " CNW Group",
        "webUrl": "https://finance.yahoo.com/news/qulipta-now-approved-health-canada-120100178.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-07-23 06:10AM",
        "title": "3 No-Brainer Dividend Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/fa2a59c1-bff5-3d9d-a22c-aa17c6ae4617/3-no-brainer-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 06:44PM",
        "title": "AbbVie cuts earnings forecast due to milestone payments",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/e3607475-27a2-34f5-ac11-47fd61b2e737/abbvie-cuts-earnings-forecast.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 04:05PM",
        "title": "AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/72409e82-d243-3588-9450-242a37a36e0f/abbvie-briefly-breaks-out.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 02:46PM",
        "title": "Immunome enters into a cancer drug collaboration with AbbVie worth up to $2.8B",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/043d8649-e13c-3ce0-b568-6b4d80d8f489/immunome-enters-into-a-cancer.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 01:46PM",
        "title": "CytomX (CTMX) Up 55% on Strategic Partnership With Moderna",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/cytomx-ctmx-55-strategic-partnership-184606299.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 10:35AM",
        "title": "Immunome Stock Jumps On Discovery Pact With AbbVie",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/immunome-stock-jumps-discovery-pact-153501768.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 08:30AM",
        "title": "3 Top U.S. Stocks to Watch in January",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9e75c6d8-de8d-325d-97d8-54b0b1a7a805/3-top-u.s.-stocks-to-watch-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 08:00AM",
        "title": "AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-immunome-announce-strategic-collaboration-130000933.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 05:11PM",
        "title": "CytomX shares surge more than 50% on Moderna partnership",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/79beb108-b773-3b30-829f-9e305420c05d/cytomx-shares-surge-more-than.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 08:00AM",
        "title": "AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-host-fourth-quarter-2022-130000276.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 07:01AM",
        "title": "AbbVie (NYSE:ABBV) Seems To Use Debt Quite Sensibly",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-nyse-abbv-seems-debt-120103434.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 05:06AM",
        "title": "Why investors should stop fixating on Apple and Tesla stock in 2023: Morning Brief",
        "publisher": " Yahoo Finance",
        "webUrl": "https://finance.yahoo.com/news/why-investors-should-stop-fixating-on-apple-and-tesla-stock-in-2023-morning-brief-100616180.html",
        "company": "ABBV"
    }
]